BridgeBio Oncology Therapeutics, Inc.

Pharmaceutical company · South San Francisco, California, United States · Nasdaq: BBOT

BridgeBio Oncology Therapeutics, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker BBOT.

Profile compiled from public records. Is this your company? Request a correction or update

BridgeBio Oncology Therapeutics at a glance

Typepharmaceutical company

HeadquartersSouth San Francisco, California, United States

Stock listingNasdaq: BBOT

SEC industryPharmaceutical Preparations

SEC CIK1869105

Frequently asked questions about BridgeBio Oncology Therapeutics

Where is BridgeBio Oncology Therapeutics headquartered?

BridgeBio Oncology Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does BridgeBio Oncology Therapeutics do?

BridgeBio Oncology Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is BridgeBio Oncology Therapeutics a public company?

Yes. BridgeBio Oncology Therapeutics, Inc. trades on Nasdaq under the ticker BBOT.

Similar companies

CytomX Therapeutics, Inc.South San Francisco, California, United States
Vistagen Therapeutics, Inc.South San Francisco, California, United States
Portola Pharmaceuticals IncSouth San Francisco, California, United States
IDEAYA Biosciences, Inc.South San Francisco, California, United States
Spruce Biosciences, Inc.South San Francisco, California, United States
Meissa Vaccines IncSouth San Francisco, California, United States
Oric Pharmaceuticals, Inc.South San Francisco, California, United States
GigaGen, Inc.South San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences